Evidence map›Paper›PMID 30847984›Full record

ArticleJournal of veterinary internal medicine2019

ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.

James W Swann, Oliver A Garden, Claire L Fellman, Barbara Glanemann, Robert Goggs, Dana N LeVine, Andrew J Mackin, Nathaniel T Whitley

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Journal of veterinary internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Coagulation status of immune-mediated polyarthritis in dogs.The Journal of small animal practice · 2025
    Article
  10. Review
  11. Article
  12. Association of miR-338-3p with survival outcomes in gastric cancer patients who received peri-operative blood transfusion.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 2 countries.

James W SwannKennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-7988-9997
Oliver A GardenSchool of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID https://orcid.org/0000-0002-4133-9487
Claire L FellmanCummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts.ORCID https://orcid.org/0000-0003-4799-3372
Barbara GlanemannRoyal Veterinary College, University of London, London, United Kingdom.ORCID https://orcid.org/0000-0003-4830-7610
Robert GoggsCollege of Veterinary Medicine, Cornell University, Ithaca, New York.ORCID https://orcid.org/0000-0001-7446-6987
Dana N LeVineCollege of Veterinary Medicine, Iowa State University, Ames, Iowa.ORCID https://orcid.org/0000-0002-1089-5640
Andrew J MackinCollege of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi.ORCID https://orcid.org/0000-0001-8465-0198
Nathaniel T WhitleyDavies Veterinary Specialists, Manor Farm Business Park, Huntingdon, United Kingdom.
Cornell University · USIowa State University · USMississippi State University · USOncology Specialists · USTufts University · USUniversity of London · GBUniversity of Oxford · GBUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune-mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. To address this inconsistency and provide evidence-based guidelines for treatment of IMHA in dogs, we identified and extracted data from studies published in the veterinary literature. We developed a novel tool for evaluation of evidence quality, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods. In combination with our clinical experience and comparable guidelines for humans afflicted with autoimmune hemolytic anemia, we used the conclusions of this process to make a set of clinical recommendations regarding treatment of IMHA in dogs, which we refined subsequently by conducting several iterations of Delphi review. Additionally, we considered emerging treatments for IMHA in dogs and highlighted areas deserving of future research. Comments were solicited from several professional bodies to maximize clinical applicability before the recommendations were submitted for publication. The resulting document is intended to provide clinical guidelines for management of IMHA in dogs. These guidelines should be implemented pragmatically, with consideration of animal, owner, and veterinary factors that may vary among cases.

Indexed as

Anemia, Hemolytic, AutoimmuneAnimalsAnticoagulantsBlood TransfusionDog DiseasesDogsFemaleImmunosuppressive AgentsMalePlatelet Aggregation InhibitorsAnticoagulantsImmunosuppressive AgentsPlatelet Aggregation InhibitorsAIHAazathioprinecaninecyclosporineguidelineIMHAmycophenolate mofetilprednisolone

Identifiers

PMID30847984
PMCPMC6524099
OpenAlexW2922441368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.